AI beats gastroenterologists in adenoma detection: trial

But greater detection doesn't necessarily mean saving lives, say researchers

An artificial intelligence program has demonstrated a higher adenoma detection rate than human gastroenterologists in a world-first, double-blinded randomised controlled trial.

The program, called EndoScreener, runs in real-time during a colonoscopy and sounds an alert when it detects a polyp. It was previously tested in a non-blinded trial.

But Chinese researchers have now completed what they claim is a world-first double-blinded trial of 962 patients, half of whom were allocated to a sham artificial intelligence (AI) — a reprogrammed